Page last updated: 2024-09-04

febuxostat and Lymphoma, Non-Hodgkin

febuxostat has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horii, M; Kobayashi, S; Kurokawa, Y; Yasu, T	1

Other Studies

1 other study(ies) available for febuxostat and Lymphoma, Non-Hodgkin

Article	Year
The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma . International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Tumor Lysis Syndrome	2016

Article

Year

The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma .

International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Tumor Lysis Syndrome

2016